India's First COVID-19 Vaccine Gets Nod For Human Trials

Hyderabad, June 29: India's first COVID-19 vaccine COVAXIN developed by Bharat Biotech got the nod for human trials by the Drug Controller General of India on Monday.

Bharat Biotech had reportedly said that the Drug Controller General of India,CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.

The drug has been developed in collaboration with the Indian Council of Medical Research  and National Institute of Virology. 

They also stated that the human clinical trials are scheduled to start across India in July 2020.



Cross Town News is the no. 1 Weekly Newspaper and Online News Portal in J&K in term of serious News. The rugged Newspaper & Portal is with a substantial difference to read and presence to feel. This newspaper has a vision to deliver the real side of truth to the public . Since it’s inception in 2013 March, It has become No. 1 News medium for people of J&K. Cross Town News has a mission to deliver high quality news across the nation within fraction of time.

Subscribe Now

Subscribe to our weekly Newsletter.